Development of procedures for early screening of smoking cessation medications in humans

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 2, 2008, Pages 216-221

  Perkins, K A ^a   Lerman, C ^b   Stitzer, M L ^c   Fonte, C A ^a   Briski, J L ^a   Scott, J A ^d   Chengappa, K N R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PRIORITY JOURNAL; REINFORCEMENT; SCORING SYSTEM; SMOKING CESSATION; TREATMENT OUTCOME; VALIDATION PROCESS; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MASS SCREENING; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 49149115209     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.30     Document Type: Article

References (25)

1. Lerman C. et al. Translational research in medication development for nicotine dependence. Nat. Rev. Drug Discov. 6, 746-762 (2007).
2. Perkins, K.A., Stitzer, M. & Lerman, C. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl.) 184, 628-636 (2006).
3. Vocci, F.J. Development of medications for addictive disorders. In Handbook of Experimental Pharmacology: Pharmacological Aspects of Drug Dependence, Towards an Integrated Neurobehavioral Approach Vol. 118 (eds. Schuster C.R. & Kuhar, M.) 473-485 (Springer, Berlin, 1996).
4. Benowitz, N.L. & Peng, M.W. Non-nicotine pharmacotherapy for smoking cessation. CNS Drugs 13, 265-285 (2000).
5. Hughes, J.R., Stead, L.F. & Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 4, CD000031 (2004).
6. Silagy, C., Lancaster, T., Stead, L., Mant, D. & Fowler, G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 3, CD000146 (2004).
7. O'Brien, C.P. A range of research-based pharmacotherapies for addiction. Science 278, 66-70 (1997).
8. Kraemer, H.C. To increase power in randomized clinical trials without increasing sample size. Psychopharmacol. Bull. 27, 217-224 (1991).
9. Benowitz, N.L., Zevin, S. & Jacob, P. 3rd. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J. Pharmacol. Exper. Ther. 287, 958-962 (1998).
10. Cousins, M.S., Stamat, H.M. & deWit, H. Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology (Berl.) 157, 243-253 (2001).
11. Shiffman, S. et al. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl.) 148, 33-40 (2000).
12. Teneggi, V., Tiffany, S.T., Squassante, L., Milleri, S., Ziviani, L. & Bye, A. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal. Psychopharmacology (Berl.) 164, 177-187 (2002).
13. Stitzer, M.L., Rand, C.S., Bigelow, G.E. & Mead, A.M. Contingent payment procedures for smoking reduction and cessation. J. Appl. Behav. Anal. 19, 197-202 (1986).
14. Weber, D. Wolff, L.S., Orleans, T., Mockenhaupt, R.E., Massett, H.A. & Vose, K.K. Smokers' attitudes and behaviors related to consumer demand for cessation counseling in the medical care setting. Nicotine Tob. Res. 9, 571-580 (2007).
15. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C. & Fagerstrom, K.-O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86, 1119-1127 (1991).
16. Sonderskov, J., Olsen, J., Sabroe, S., Meillier, L. & Overvad, K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am. J. Epidemiol. 145, 309-318 (1997).
17. Tidey, J.W., O'Neill, S.C. & Higgins, S.T. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Exp. Clin. Psychopharmacol. 10, 241-247 (2002).
18. Schneider, N.G. et al. Preferences among four combination nicotine treatments. Psychopharmacology (Berl.) 187, 476-485 (2006).
19. Alessi, S.M., Badger, G.J. & Higgins, S.T. An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp. Clin. Psychopharmacol. 12, 276-287 (2004).
20. Lamb, R.J., Morral, A.R., Kirby, K.C., Iguchi, M.Y. & Galbicka, G. Shaping smoking cessation using percentile schedules. Drug Alcohol Depend. 76, 247-259 (2004).
21. Roll, J.M. & Higgins, S.T. A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend. 58, 103-109 (2000).
22. Perkins, K.A., Lerman, C., Keenan, J., Fonte, C. & Coddington, S. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Nicotine Tob. Res. 6: 501-507 (2004).
23. Cox, L.S., Tiffany, S.T. & Christen, A.G. Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings. Nicotine Tob. Res. 3, 7-16 (2001).
24. Hughes, J.R., Gust, S.W., Skoog, K., Keenan, R.M. & Fenwick, J.W. Symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 48, 52-59 (1991).
25. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4, 149-159 (2002).